A. Kolivras, F. Dehavay, D. Delplace, Francesco Feoli, Isabelle Meiers, Laurenzo Milone, C. Olemans, U. Sass, A. Theunis, Curtis T. Thompson, L. van de Borne, Bertrand Richert
2020.4.18JAAD Case Reports
tlooto Summary
A 23-year-old man presented with a 3-day history of acute-onset, violaceous, infiltrated, and painful plaques on the toes and lateral aspect of the feet, which had been stopped 1 month before to minimize immunosuppression during the COVID-19 pandemic.
Abstract
CASE REPORT A 23-year-old man presented with a 3-day history of acute-onset, violaceous, infiltrated, and painful plaques on the toes and lateral aspect of the feet. The appearance of the plaques was preceded by 3 days of a low-grade fever (37.78C) and a dry cough. His clinical history was notable for psoriasis, which had been treated with secukinumab for 30 months; however, the secukinumab had been stopped 1 month before to minimize immunosuppression during the COVID-19 pandemic. No additional treatment had been initiated. The patient had many violaceous, infiltrated, and painful plaques on an erythematous background on the dorsal aspect of the toes and the lateral sides of the feet (Fig 1). The hands and fingers were unaffected. The patient did not have a history of Raynaud phenomenon, acrocyanosis, chilblains (perniosis), or photosensitivity. A complete skin examination result was otherwise unremarkable, and dermoscopy showed normal proximal nail folds. A
Citation format
KOLIVRAS, A., et al. Coronavirus (COVID-19) infection–induced chilblains: A case report with histopathologic findings. JAAD Case Reports, 2020, 6: 489–492.